Literature DB >> 25527479

A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy.

Masakazu Haneda1, Kazunori Utsunomiya, Daisuke Koya, Tetsuya Babazono, Tatsumi Moriya, Hirofumi Makino, Kenjiro Kimura, Yoshiki Suzuki, Takashi Wada, Susumu Ogawa, Masaaki Inaba, Yoshihiko Kanno, Takashi Shigematsu, Ikuto Masakane, Ken Tsuchiya, Keiko Honda, Kazuko Ichikawa, Kenichiro Shide.   

Abstract

The Joint Committee on Diabetic Nephropathy has revised its Classification of Diabetic Nephropathy (Classification of Diabetic Nephropathy 2014) in line with the widespread use of key concepts such as the estimated glomerular filtration rate (eGFR) and chronic kidney disease. In revising the Classification, the Committee carefully evaluated, as relevant to current revision, the report of a study conducted by the Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan. Major revisions to the Classification are summarized as follows: (1) eGFR is substituted for GFR in the Classification; (2) the subdivisions A and B in stage 3 (overt nephropathy) have been reintegrated; (3) stage 4 (kidney failure) has been redefined as a GFR less than 30 mL/min/1.73 m(2), regardless of the extent of albuminuria; and (4) stress has been placed on the differential diagnosis of diabetic nephropathy versus non-diabetic kidney disease as being crucial in all stages of diabetic nephropathy.

Entities:  

Mesh:

Year:  2015        PMID: 25527479     DOI: 10.1007/s10157-014-1057-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  3 in total

1.  Summary of revisions to the 2014 Clinical Practice Recommendations.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.

Authors:  Takashi Wada; Masakazu Haneda; Kengo Furuichi; Tetsuya Babazono; Hiroki Yokoyama; Kunitoshi Iseki; Shin-ichi Araki; Toshiharu Ninomiya; Shigeko Hara; Yoshiki Suzuki; Masayuki Iwano; Eiji Kusano; Tatsumi Moriya; Hiroaki Satoh; Hiroyuki Nakamura; Miho Shimizu; Tadashi Toyama; Akinori Hara; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2013-10-17       Impact factor: 2.801

3.  Summary of revisions for the 2013 clinical practice recommendations.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

  3 in total
  32 in total

1.  Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.

Authors:  Kengo Furuichi; Miho Shimizu; Yukio Yuzawa; Akinori Hara; Tadashi Toyama; Hiroshi Kitamura; Yoshiki Suzuki; Hiroshi Sato; Noriko Uesugi; Yoshifumi Ubara; Junichi Hohino; Satoshi Hisano; Yoshihiko Ueda; Shinichi Nishi; Hitoshi Yokoyama; Tomoya Nishino; Kentaro Kohagura; Daisuke Ogawa; Koki Mise; Yugo Shibagaki; Hirofumi Makino; Seiichi Matsuo; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2017-10-27       Impact factor: 2.801

2.  Worsening of proteinuria caused by combination therapy of hypertonic saline and low-dose furosemide for treatment of acute decompensated heart failure with overt diabetic nephropathy.

Authors:  Koichi Nishimura; Shinichi Hirotani; Yoshitaka Okuhara; Tomotaka Ando; Daisuke Morisawa; Makiko Oboshi; Hisashi Sawada; Akiyo Eguchi; Toshihiro Iwasaku; Yoshiro Naito; Tohru Masuyama
Journal:  J Cardiol Cases       Date:  2015-08-28

3.  Factors associated with atrial fibrillation in Japanese patients with type 2 diabetes mellitus: a cross-sectional study.

Authors:  Natsuki Honda; Akinobu Ochi; Sadahiko Uchimoto; Yoshinori Kakutani; Yuko Yamazaki; Tomoaki Morioka; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto
Journal:  Diabetol Int       Date:  2022-01-24

4.  Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.

Authors:  Ping-Min Chen; Takashi Wada; Chih-Kang Chiang
Journal:  Clin Exp Nephrol       Date:  2016-06-23       Impact factor: 2.801

Review 5.  Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.

Authors:  Giorgina B Piccoli; Giorgio Grassi; Gianfranca Cabiddu; Marta Nazha; Simona Roggero; Irene Capizzi; Agostino De Pascale; Adriano M Priola; Cristina Di Vico; Stefania Maxia; Valentina Loi; Anna M Asunis; Antonello Pani; Andrea Veltri
Journal:  Rev Diabet Stud       Date:  2015-08-10

6.  Clinical background of Japanese patients with type 1 diabetes mellitus who have received insulin therapy for 50 years or longer.

Authors:  Toshika Otani; Tadasu Kasahara; Junnosuke Miura; Yasuko Uchigata; Tetsuya Babazono
Journal:  Diabetol Int       Date:  2019-04-11

7.  Association of crossing capillaries in the finger nailfold with diabetic retinopathy in type 2 diabetes mellitus.

Authors:  Maiko Shikama; Nao Sonoda; Akiko Morimoto; Sayaka Suga; Tetsuya Tajima; Junji Kozawa; Norikazu Maeda; Michio Otsuki; Taka-Aki Matsuoka; Iichiro Shimomura; Yuko Ohno
Journal:  J Diabetes Investig       Date:  2020-11-10       Impact factor: 4.232

8.  Reliability and validity of revised and short form versions of diabetes diet-related quality of life scale.

Authors:  Eiko Sato; Ryota Ochiai; Taiga Shibayama; Masakazu Nishigaki; Yoshiki Abe; Tasuku Sawa; Yoshimi Suzukamo; Keiko Kazuma
Journal:  Diabetol Int       Date:  2016-11-04

9.  Association of abdominal obesity with crossing capillaries in the finger nailfold in type 2 diabetes mellitus.

Authors:  Maiko Shikama; Nao Sonoda; Akiko Morimoto; Sayaka Suga; Tetsuya Tajima; Junji Kozawa; Norikazu Maeda; Michio Otsuki; Taka-Aki Matsuoka; Iichiro Shimomura; Yuko Ohno
Journal:  Diabetol Int       Date:  2021-01-01

10.  Pill Counting in the Determination of Factors Affecting Medication Adherence in Patients with Type 2 Diabetes: A Retrospective Observational Study.

Authors:  Megumi Shiomi; Momoka Kurobuchi; Yoichi Tanaka; Tesshu Takada; Katsuya Otori
Journal:  Diabetes Ther       Date:  2021-06-13       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.